Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.
Serious infections with salmonellae remain a threat in many human populations. Despite extensive study of salmonella infections in animals and clinical experience with killed cellular vaccines, there are no vaccines against serotypes other than Salmonella typhi licensed for human use. Serum antibodies to the O-specific polysaccharide (O-SP) of salmonellae protect mice against invasive infection. In order to render it immunogenic, we have conjugated the O-SP of Salmonella typhimurium to carrier proteins by various schemes. O-SP conjugated to tetanus toxoid (O-SP-TT) elicited antibodies in outbred mice after three subcutaneous injections without adjuvant. The O-SP alone elicited no detectable antibody. The antibody response to O-SP-TT was boosted by successive doses and consisted of immunoglobulin G (IgG) and IgM. Most mice only produced antibodies specific for the abequose (O:4 factor) region of the O-SP. Occasional animals also produced antibodies to the core oligosaccharide. Immunized mice were protected against intraperitoneal challenge with S. typhimurium, demonstrating a 160-fold increase in the 50% lethal dose. Passive immunization with conjugate-induced IgM or IgG also protected against challenge. These results indicate that an O-SP-TT conjugate, when given by a route and formulation acceptable for human use, protects mice against challenge with S. typhimurium.
Watson
D C
DC
Laboratory of Developmental and Molecular Immunity, National Institute of Child Health and Human Development, Bethesda, Maryland 20892.
Robbins
J B
JB
Szu
S C
SC
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D000918:Antibody Specificity; D001428:Bacterial Vaccines / Q000276:immunology*; D002240:Carbohydrate Sequence; D007114:Immunization; D007116:Immunization, Passive; D005779:Immunodiffusion; D051379:Mice; D019081:O Antigens; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D012480:Salmonella Infections / Q000517:prevention & control*; D012486:Salmonella typhimurium / Q000276:immunology*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D019081:O Antigens; D011135:Polysaccharides, Bacterial